The editors and staff of Neuro-Oncology are thrilled to announce that the journal's Impact Factor has increased yet again, from 5.723 to an impressive 6.180 for 2012. The journal is now ranked 9th of 191 clinical neurology journals (top 5%) and 24th of 196 oncology journals (top 12%).
The Impact Factor, a metric used to assess journal quality, is calculated by dividing the number of articles published in the previous two years into the number of citations of those articles in the reported year (ie, the 2012 number was determined by dividing the number of 2012 citations of articles published in 2010 and 2011 by the total number of articles published in 2010 and 2011). The Impact Factor is published annually by Thomson Reuters in Journal Citation Reports.
Neuro-Oncology has undergone several changes since it was founded in 1997, most in only the past few yearsits publication frequency increased to bi-monthly in 2008 and monthly in 2010, and it changed publishers to Oxford University Press. Throughout, we have maintained our commitment to publishing only the most significant research in the field, with an acceptance rate of about 18% -20%. A high submission rate has allowed us to increase the number of articles published in each issue by about the same rate. We are reviewing, accepting, and publishing more papers than ever before, and as illustrated by our 2012 Impact Factor, those papers are being read and cited more than ever before, as well.
Of course, we could not have succeeded without the tireless efforts of the journal's authors, reviewers, and editors over the past year. We look forward to working with them to ensure that Neuro-Oncology remains the top journal in its field. 
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